“In mouse heart-attack models, blocking succinate dehydrogenase in cardiac fibroblasts suppressed fibroblast activation and reduced scar formation, improving cardiac function; cardiomyocyte-only blockade increased proliferation transiently but was insufficient by itself.”

Checks out so far. 2 hold up so far.

0.9475 under ledger-default@0.3.0 at snapshot 27745 for all claims together. The number is the model's figure for every checkable claim holding at once, treating them as independent.

The statement as a whole, read from the 2 claims below. Each claim is scored on its own; this reading only counts them. Provisional until audited.

Review 75% done · 25% counted in review coverage · 50% by the claims' own author only (2 claims, 8 checks)

Share:

Checked in Galedra: score 0.95, strongly supported · not yet reviewed by anyone else “In mouse heart-attack models, blocking succinate dehydrogenase in cardiac fibroblasts suppressed fibroblast activation and reduced scar formation, improving cardiac function; cardiomyocyte-only…” https://galedra.org/investigations/01a0eada-9eb4-7173-994b-48afa04ee6b1

“In mouse heart-attack models, blocking succinate dehydrogenase in cardiac fibroblasts suppressed fibroblast activation and reduced scar formation, resulting in improved cardiac function.”

Supported · 0.9734 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited.

3 of 4 review checks done · 1 counted · 2 by the author only

See the evidence · Claim card

“In mouse heart-attack models, blocking succinate dehydrogenase specifically in cardiomyocytes produced a transient proliferation increase that was insufficient by itself to improve heart function.”

Supported · 0.9734 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited.

3 of 4 review checks done · 1 counted · 2 by the author only

See the evidence · Claim card